Revolutionizing Cancer Treatment | BeOne Medicines
Dec 23, 2025 · BeOne Medicines, formerly BeiGene, is committed to developing innovative cancer medicines by partnering globally to serve patients everywhere.
百创新药，济世惠民 | 百济神州
BeOne Medicines is committed to developing innovative medicines against cancer by partnering with the global community to serve patients everywhere.
百济神州更名BeOne并迁址瑞士|美国|开曼|英国|欧洲_网易订阅
Jun 6, 2025 · 5月27日，百济神州宣布其新英文名称BeOne Medicines Ltd.（简称BeOne）正式启用，取代原来的 BeiGene（中文名称不变）； 注册地从开曼迁址瑞士；自存续注册生效日起，公司适用根 …
百济神州启用新英文名称BeOne Medicines并将注册地迁至瑞士，开启 …
Jun 11, 2025 · BeOne Medicines是一家全球肿瘤学公司，总部设在瑞士，致力于研发创新疗法，使全球癌症患者能够以更可负担的价格获得更便捷的治疗。
BeOne Medicines遷址瑞士後正式啟動，開啟全球腫瘤治療新篇章
May 29, 2025 · 關於BeOne BeOne Medicines前身為BeiGene，是一家總部位於瑞士的全球性腫瘤公司，致力於發現和開發對全球癌症病患而言更可負擔且更可及的創新療法。 透過內部能力與合 …
BeiGene更名BeOne Medicines 遷址瑞士加速全球布局 | NOW健康｜健 …
Jun 8, 2025 · 全球腫瘤治療創新公司BeiGene Ltd.（百濟神州有限公司）近日宣布，其英文名稱已正式啟用為BeOne Medicines Ltd.，並已完成註冊地從開曼群島遷至瑞士的程序。
以后请叫BeOne Medicines，百济神州改名！_BeiGene_癌症_名称
Nov 15, 2024 · 11月14日，百济神州宣布打算将公司的英文名称由BeiGene更改为BeOne Medicines。 同时，中文名保持不变。 一旦名称获得股东批准， 百济神州在纳斯达克的股票代码将更改为“ONC”。 …
BeOne Medicines - Wikipedia
BeOne was founded in late 2010 by John V. Oyler, [11] an American entrepreneur who serves as the company's chief executive officer and chairman, [35] alongside Xiaodong Wang, a Chinese American …
BeOne Medicines Launches Following Redomiciliation to ... - BioSpace
May 27, 2025 · About BeOne BeOne Medicines, formerly known as BeiGene, is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are …
About Us - BeOne Medicines
BeOne Medicines develops next-gen cancer treatments, delivering them faster and more equitably worldwide.